Periventricular Endothelial Cell Co-Transplantation for Interneuron Migration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing cell-based therapies for neuropsychiatric disorders, such as autism and schizophrenia, face challenges with the slow migration and integration of transplanted GABAergic interneurons, necessitating a faster and more effective method to facilitate neuronal migration and integration in the host brain.

Innovation Solution

Generation of human periventricular endothelial cells using human pluripotent stem cells, cultured with Wnt7a, GABA, and specific growth factors, to provide guidance cues for GABAergic interneuron migration, followed by co-transplantation with neuronal cells.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If human stem cell derived interneuron precursors are transplanted, then new cells with intrinsic plasticity are introduced to overcome cellular deficits, but the migration from graft site to host tissue takes four to seven months which is too slow for clinical translation

Engineering Contradiction:
Improvecellular deficits correctionVSAvoidmigration time
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent introduces periventricular endothelial cells as intermediary structures that secrete guidance cues (such as netrin-1, semaphorin 3A, and other chemokines) to mediate and accelerate interneuron migration. These endothelial cells form a migratory pathway that guides transplanted interneurons from the graft site to their target locations in the host brain, reducing migration time from months to weeks while maintaining proper cellular integration

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs preliminary action by pre-differentiating stem cells into interneuron precursors with enhanced migratory capacity before transplantation. Additionally, the graft sites are prepared with pre-formed endothelial cell networks that secret guidance cues in advance, creating a ready-made migratory pathway that immediately guides transplanted cells upon implantation, thereby accelerating the overall integration process

Inventive Principle:
Principle #10Preliminary action

2Reliability

If transplantation is performed to introduce new cells, then cellular deficits are addressed, but the integration and functional incorporation into host brain circuitry is insufficient without proper migration

Engineering Contradiction:
Improvecellular deficits correctionVSAvoidintegration efficiency
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

Periventricular endothelial cells serve as intermediary structures that facilitate interneuron integration by secreting guidance cues and forming physical migratory pathways. These endothelial cells create a supportive environment that guides transplanted interneurons to their appropriate target zones in the host brain, ensuring proper circuitry integration and functional incorporation

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent utilizes parameter changes by modifying the chemical and physical environment along the migration pathway. Endothelial cells alter local concentrations of guidance cues (such as increasing netrin-1 and semaphorin 3A levels) and modify extracellular matrix properties to enhance interneuron migratory capacity and directional guidance, thereby improving integration efficiency

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12564610B2Human periventricular endothelial cell therapy for neuropsychiatric disorders
Publication Date: 2026.03.03 THE MCLEAN HOSPITAL CORP
  • US12564610B2 patent drawing
  • US12564610B2 patent drawing
  • US12564610B2 patent drawing

AI summary

Described herein are methods for generating human forebrain endothelial cells, compositions comprising the cells, and methods of use thereof in therapy. Provided herein are methods for generation of human embryonic forebrain-like endothelial cells (e.g., periventricular endothelial cells) from human embryonic stem cells; the methods include addition or GABA and WNT7A for efficient differentiation, and isolation of GABRB37CD31+ cell population by FACS.